The adeno-associated virus (AAV) capsid variant known as “true type” (AAV-TT) is a capsid with enhanced central nervous system tropism and efficient retrograde transport across brain circuits. This property enables AAV-TT to transduce neurons in multiple regions projecting to the site of injection, as previously shown in rodent and sheep models. Such spreading offers the potential for broad therapeutic vector distribution to functionally connected brain areas via a single intraparenchymal administration. To assess the clinical potential of AAV-TT, we delivered a green fluorescent protein (GFP)-expressing AAV-TT vector into the left commissural putamen of two young adult Macaca fascicularis. For comparison, two additional animals received AAV9-GFP. Four weeks post-injection, animals were euthanized, and whole-brain transduction patterns were analyzed using a dedicated Aiforia® deep learning-based image analysis algorithm to quantify GFP+ neurons. We observed GFP expression in structures known to innervate the injection site, consistent with retrograde transport. Both AAV-TT and AAV9 showed similar overall distribution patterns, but AAV-TT demonstrated modestly enhanced neuronal transduction efficiency compared with AAV9. This study provides the first direct comparison of AAV-TT and AAV9 in the adult nonhuman primate brain and positions AAV-TT as a promising tool for disease modeling and therapeutic interventions in neurodegenerative disorders targeting anatomically distributed neural circuits.
MarkakisEA, VivesKP, BoberJ, et al.Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain. Mol Ther2010;18(3):588–593; doi: 10.1038/mt.2009.286
2.
MasamizuY, OkadaT, KawasakiK, et al.Local and retrograde gene transfer into primate neuronal pathways via adeno-associated virus serotype 8 and 9. Neuroscience2011;193:249–258; doi: 10.1016/j.neuroscience.2011.06.080
3.
San SebastianW, SamaranchL, HellerG, et al.Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain. Gene Ther2013;20(12):1178–1183; doi: 10.1038/GT.2013.48
4.
GeritsA, VancraeyenestP, VreysenS, et al.Serotype-dependent transduction efficiencies of recombinant adeno-associated viral vectors in monkey neocortex. Neurophotonics2015;2(3):e031209; doi: 10.1117/1.nph.2.3.031209
5.
GreenF, SamaranchL, ZhangHS, et al.Axonal transport of AAV9 in nonhuman primate brain. Gene Ther2016;23(6):520–526; doi: 10.1038/GT.2016.24
6.
RicoAJ, CorchoA, ChocarroJ, et al.Development and characterization of a non-human primate model of disseminated synucleinopathy. Front Neuroanat2024;18:1355940; doi: 10.3389/FNANA.2024.1355940
7.
TordoJ, O’LearyC, AntunesASLM, et al.A novel adeno-associated virus capsid with enhanced neurotropism corrects a lysosomal transmembrane enzyme deficiency. Brain2018;141(7):2014–2031; doi: 10.1093/brain/awy126
8.
NaidooJ, StanekLM, OhnoK, et al.Extensive transduction and enhanced spread of a modified AAV2 capsid in the non-human primate CNS. Mol Ther2018;26(10):2418–2430; doi: 10.1016/j.ymthe.2018.07.008
9.
DavidssonM, WangG, Aldrin-KirkP, et al.A systematic capsid evolution approach performed in vivo for the design of AAV vectors with tailored properties and tropism. Proc Natl Acad Sci U S A2019;116(52):27053–27062; doi: 10.1073/PNAS.1910061116
10.
CommissoB, DingL, VaradiK, et al.Stage-dependent remodeling of projections to motor cortex in ALS mouse model revealed by a new variant retrograde-AAV9. Elife2018;7:e36892; doi: 10.7554/ELIFE.36892
11.
O’LearyC, ForteG, MitchellNL, et al.Intraparenchymal convection enhanced delivery of AAV in sheep to treat Mucopolysaccharidosis IIIC. J Transl Med2023;21(1):1–17; doi: 10.1186/s12967-023-04208-1
12.
AlbaughDL, SmithY, GalvanA. Comparative analyses of transgene expression patterns after intra-striatal injections of rAAV2-retro in rats and rhesus monkeys: A light and electron microscopic study. Eur J Neurosci2020;52(12):4824–4839; doi: 10.1111/EJN.15027
13.
WeissAR, LiguoreWA, DomireJS, et al.Intra-striatal AAV2.retro administration leads to extensive retrograde transport in the rhesus macaque brain: Implications for disease modeling and therapeutic development. Sci Rep2020;10(1):6970; doi: 10.1038/s41598-020-63559-7
14.
IsaT. Double viral vector intersectional approaches for pathway-selective manipulation of motor functions and compensatory mechanisms. Exp Neurol2022;349:113959; doi: 10.1016/j.expneurol.2021.113959
15.
CushnieAK, El-NahalHG, BohlenMO, et al.Using RAAV2-retro in rhesus macaques: Promise and caveats for circuit manipulation. J Neurosci Methods2020;345:108859; doi: 10.1016/j.jneumeth.2020.108859
16.
LanciegoJL, ObesoJA. Functional neuroanatomy of the normal and pathological basal ganglia. Cold Spring Harb Perspect Med2026;16(1):a041617; doi: 10.1101/CSHPERSPECT.A041617
17.
SullivanJA, StanekLM, LukasonMJ, et al.Rationally designed AAV2 and AAVrh8R capsids provide improved transduction in the retina and brain. Gene Ther2018;25(3):205–219; doi: 10.1038/s41434-018-0017-8
18.
RaoufR, LolignierS, SextonJE, et al.Inhibition of somatosensory mechanotransduction by annexin A6. Sci Signal2018;11(535):eaao2060; doi: 10.1126/scisignal.aao2060
19.
BennettA, HullJ, JolinonN, et al.Comparative structural, biophysical, and receptor binding study of true type and wild type AAV2. J Struct Biol2021;213(4):107795; doi: 10.1016/j.jsb.2021.107795
20.
WangJ-H, GesslerDJ, ZhanW, et al.Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduct Target Ther2024;9(1):78; doi: 10.1038/s41392-024-01780-w
21.
SurdykaMM, FigielM. Retrograde capabilities of adeno-associated virus vectors in the central nervous system. BioTechnologia (Pozn)2021;102(4):473–478; doi: 10.5114/BTA.2021.111111
22.
GrimmD, KernA, RittnerK, et al.Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum Gene Ther1998;9(18):2745–2760; doi: 10.1089/HUM.1998.9.18-2745
23.
ZeltnerN, KohlbrennerE, ClémentN, et al.Near-perfect infectivity of wild-type AAV as benchmark for infectivity of recombinant AAV vectors. Gene Ther2010;17(7):872–879; doi: 10.1038/gt.2010.27
24.
FagoneP, Fraser WrightJ, NathwaniAC, et al.Systemic errors in quantitative polymerase chain reaction titration of self-complementary adeno-associated viral vectors and improved alternative methods. Hum Gene Ther Methods2012;23(1):1–7; doi: 10.1089/hgtb.2011.104
25.
KohlbrennerE, HenckaertsE, RaptiK, et al.Quantification of AAV particle titers by infrared fluorescence scanning of coomassie-stained sodium dodecyl sulfate-polyacrylamide gels. Hum Gene Ther Methods2012;23(3):198–203; doi: 10.1089/hgtb.2012.049
26.
LanciegoJL, VázquezA. The basal ganglia and thalamus of the long-tailed macaque in stereotaxic coordinates. A template atlas based on coronal, sagittal and horizontal brain sections. Brain Struct Funct2012;217(2):613–666; doi: 10.1007/S00429-011-0370-5
27.
PenttinenAM, ParkkinenI, BlomS, et al.Implementation of deep neural networks to count dopamine neurons in substantia nigra. Eur J Neurosci2018;48(6):2354–2361; doi: 10.1111/EJN.14129
28.
MartinRF, BowdenDM. A stereotaxic template atlas of the macaque brain for digital imaging and quantitative neuroanatomy. Neuroimage1996;4(2):119–150; doi: 10.1006/nimg.1996.0036
29.
LanciegoJL, WouterloodFG. A half century of experimental neuroanatomical tracing. J Chem Neuroanat2011;42(3):157–183; doi: 10.1016/j.jchemneu.2011.07.001
30.
LanciegoJL, WouterloodFG. Neuroanatomical tract-tracing techniques that did go viral. Brain Struct Funct2020;225(4):1193–1224; doi: 10.1007/S00429-020-02041-6
31.
SørensenKE. Projections of the entorhinal area to the striatum, nucleus accumbens, and cerebral cortex in the guinea pig. J Comp Neurol1985;238(3):308–322; doi: 10.1002/CNE.902380306
32.
TotterdellS, MeredithGE. Topographical organization of projections from the entorhinal cortex to the striatum of the rat. Neuroscience1997;78(3):715–729; doi: 10.1016/S0306-4522(96)00592-1
33.
SzaboJ. Organization of the ascending striatal afferents in monkeys. J Comp Neurol1980;189(2):307–321; doi: 10.1002/CNE.901890207
34.
StratfordTR, WirtshafterD. Ascending dopaminergic projections from the dorsal raphe nucleus in the rat. Brain Res1990;511(1):173–176; doi: 10.1016/0006-8993(90)90239-8
35.
ShenS, BryantKD, BrownSM, et al.Terminal n-linked galactose is the primary receptor for adeno-associated virus. J Biol Chem2011;286(15):13532–13540; doi: 10.1074/jbc.M110.210922
36.
AkacheB, GrimmD, PandeyK, et al.The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. J Virol2006;80(19):9831–9836; doi: 10.1128/jvi.00878-06
37.
MoyerTC, HoffmanBA, ChenW, et al.Highly conserved brain vascular receptor ALPL mediates transport of engineered AAV vectors across the blood-brain barrier. Mol Ther2025;33(8):3902–3916; doi: 10.1016/j.ymthe.2025.04.046
38.
BunualesM, GardunoA, ChillonM, et al.Characterization of brain transduction capability of a BBB-penetrant AAV vector in mice, rats and macaques reveals differences in expression profiles. Gene Ther2024;31(9–10):455–466; doi: 10.1038/s41434-024-00466-w
39.
HuangQ, ChenAT, ChanKY, et al.Targeting AAV vectors to the central nervous system by engineering capsid–receptor interactions that enable crossing of the blood–brain barrier. PLoS Biol2023;21(7):e3002112; doi: 10.1371/journal.pbio.3002112
40.
LeibD, ChenY, TecedorL, et al.Optimized AAV capsids for diseases of the basal ganglia show robust potency and distribution in adult nonhuman primates. bioRxiv2024; doi: 10.1101/2024.05.02.592211
41.
ChuapocoM, FlytzanisN, GoedenN, et al.Intravenous functional gene transfer throughout the brain of non-human primates using AAV. Res Sq2023:rs.3.rs–r1370972; doi: 10.21203/RS.3.RS-1370972/V1
42.
ChocarroJ, LanciegoJL. Adeno-associated viral vectors for modeling Parkinson’s disease in non-human primates. Neural Regen Res2026;21(1):224–232; doi: 10.4103/NRR.NRR-D-24-00896
43.
KondratovO, KondratovaL, MandelRJ, et al.A comprehensive study of a 29-capsid AAV library in a non-human primate central nervous system. Mol Ther2021;29(9):2806–2820; doi: 10.1016/j.ymthe.2021.07.010
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
